Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02566395 · ClinicalTrials.gov registry record · Phase 3
Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies
A Phase 3 study, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 10
- Enrollment target
NCT02566395: Completed Phase 3 study, sponsored by Northwell Health.
NCT02566395 is a Phase 3 study that has completed, run by Northwell Health. The registered enrollment target is 10 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02566395, a Phase 3 study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 10 participants
- Enrollment target
Study Summary
This clinical pilot trial is intended to evaluate the feasibility, efficacy and safety of hematopoietic stem cell transplantation (HSCT) from Human Leukocyte Antigen (HLA)-mismatched related donors for children and young adults with hematologic malignancies who lack a suitably matched related or unrelated donor. The methodology will be one that has been successfully utilized in adult patients at Thomas Jefferson University.
Primary Outcome
Absolute neutrophil count \>500/microliter x 3 consecutive days
Interventions
- DRUG Cyclophosphamide
- RADIATION Radiation
- BIOLOGICAL Donor Lymphocyte Infusion (DLI)
- BIOLOGICAL Haploidentical Stem Cell Transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-12 |
| Est. Completion | 2022-02-14 |
| Phase | Phase 3 |
What the finished NCT02566395 record still lists
NCT02566395 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Cyclophosphamide is the first listed.
NCT02566395 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02566395 about?
NCT02566395 is a clinical study titled "Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies". This clinical pilot trial is intended to evaluate the feasibility, efficacy and safety of hematopoietic stem cell transplantation (HSCT) from Human Leukocyte Antigen (HLA)-mismatched related donors for children and young adults with hematologic malignancies who lack a suitably matched related or unr...
What is the current status of trial NCT02566395?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2014-12. Estimated completion is 2022-02-14.
What interventions are being tested in trial NCT02566395?
The interventions under investigation include: Cyclophosphamide (DRUG), Radiation (RADIATION), Donor Lymphocyte Infusion (DLI) (BIOLOGICAL), Haploidentical Stem Cell Transplantation (BIOLOGICAL).
Who is sponsoring clinical trial NCT02566395?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02566395's enrollment target sits among peer trials
10 1989th of 2000 higher than 9 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia